MRNA is in completing the continuation pattern and with some volume it will breakout
Hi traders, Quite a good trading day on Wednesday, I ended up around BE for the day but I felt generally in good control. One small improvement could've been made in early exit of my first trade. My Trades: 1) ALC - SHORT @56.94, I made a small mistake of not exiting earlier as ALC wasn't reacting at all to the market going down again. -1.06 2) MRNA - LONG...
Gilead Sciences , Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency...
What is XBi? XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with...
Hi traders, The other day I posted a reverse entry which happened to be a loser as well, but I told you it typically pays off. On Friday I got to prove it when WDC didn't react the way I planned and that got me thinking if the other direction wasn't a better idea... and it was! The Trades: 1) WDC - SHORT @38.73 - terrible fill at the break of 39, in hindsight I...
engages in the development of transformative medicines based on messenger ribonucleic acid. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. GOOD OF START of the company of may...
Bullish: Every week since the low has closed green except this week. Bearish: The last week of each month have been particularly bearish since January. The overwhelming bull trend that's taken place over the past few weeks have been disorienting. My bias is now leaning neutral. I will consider the downtrend on hold if the monthly closes above the 17th of April...
GILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir. Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance. A close below...
MRNA is the leading play on the COVID-19 vaccine list. The stock broke out above a beautiful bullish ascending triangle this month, and momentum continues to work in favor of the stock.
SO Moderna spiked from roughly $19.07 to $28 est. in less than 45 minutes after rumors broke into confirmations ending with headlines as Mordova has officially announced a vaccination for COVID-19 has been developed yet with months of red tape ahead of us (still have yet to undergo animal testing, clinical trials, human testing, then once the vaccination has been...
$MRNA is working on a vaccine for the coronavirus. If the stock breaks out above $36, it should take off. Risk looks to be minimal. The trade should work out right away. Can do buy stop at $36.01 and risk 20 to 50 cents, depending on your risk tolerance. Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger...
#Moderna is resting after break out. $36 is the critical resistance. watch for rsi and volume.
Moderna is one of the best pick for COVID-19 vaccine. They have already started dosing patients and expect the vaccine to be available for high-risk people like healthcare workers in the Fall this year. The strength is rising and needs to close above $36 by the end of next week.
Update from Moderna CEO tomorrow on current supply and R&D trials. Volatility dropping from highs.
This is a great example how forward looking indicators, when used in conjunction, can provide the most accurate support and resistance levels. While most indicators are lagging, projection indicators that help define major price pivots are predictive. MRNA ran into the upper MSP boundaries and has been trading between the bands with TDS lines from prior signals...
held GILD , MRNA calls over the weekend gilead only phase 3 coronavirus cure moderna first coronavirus vaccine